Prosecution Insights
Last updated: May 29, 2026

Examiner: GAO, ASHLEY HARTMAN

Tech Center 1700 • Art Units: 1644 1646 1678 1783

This examiner grants 60% of resolved cases

Performance Statistics

59.8%
Allow Rate
-5.2% vs TC avg
132
Total Applications
+38.9%
Interview Lift
1213
Avg Prosecution Days
Based on 82 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
3.9%
§102 Novelty
49.6%
§103 Obviousness
22.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17924748 DETECTION METHOD OF TARGET MOLECULE IN SPECIMEN AND DETECTION KIT FOR TARGET MOLECULE Non-Final OA Yokogawa Electric Corporation
17423133 METHOD FOR SELECTING CELLS HIGHLY RESPONSIVE TO TARGET SUBSTANCE, AND METHOD FOR DETERMINING CONCENTRATION OF TARGET SUBSTANCE WITH UNKNOWN CONCENTRATION IN SPECIMEN Final Rejection HAMAMATSU PHOTONICS K.K.
18625703 NOVEL PD-1 BINDING DOMAINS Final Rejection INCYTE CORPORATION
18065736 MEASURING FREQUENCY OF PATHOGEN-SPECIFIC T CELLS IN PERIPHERAL BLOOD Non-Final OA Thomas Jefferson University
16961026 Fusion Protein Extensions Final Rejection NantBio, Inc.
17128599 BISPECIFIC SIGNALING AGENTS AND USES THEREOF Final Rejection Universiteit Gent
17056626 Composition of Concentrated Human Immunoglobulins Final Rejection Laboratoire Francais du Fractionnement et des Biotechnologies
18032597 IMPROVED DETECTION OF LYMPHOCYTE - TARGET CELL INTERACTION Non-Final OA LUMICKS CA HOLDING B.V.
17964053 NITROGEN-SULFUR CO-DOPED TI3C2-MXENE NANOSHEET AND PREPARATION METHOD AND APPLICATION THEREOF Non-Final OA Civil Aviation University of China
17292588 METHOD FOR PREVENTING IRREGULAR DETECTION IN IMMUNOASSAY IN AUTOMATIC ANALYZER, AND IMMUNOASSAY REAGENT Non-Final OA SEKISUI MEDICAL CO., LTD.
18024603 CONJUGATES HAVING AN ENZYMMATICALLY RELEASABLE DETECTION MOIETY AND A BARCODE MOIETY Non-Final OA Miltenyi Biotec B.V. & Co. KG
18277237 Immunoassay for Detecting Eosinophilic Esophagitis Non-Final OA Nordic Bioscience A/S
17925999 HYPER-SIALYLATED IMMUNOGLOBULIN Final Rejection Momenta Pharmaceuticals, Inc.
18112527 ANTIBODY COMBINATION FOR SUBSTITUTING SIDE SCATTER SIGNAL IN MASS CYTOMETRY HEMATOLOGIC TUMOR IMMUNOPHENOTYPING AND USE THEREOF Final Rejection Zhejiang Puluoting Health Technology Co., Ltd.
18109628 IMMUNOSTAINING USING PROTEIN CONJUGATES Non-Final OA Advanced Biosystems, Inc.
17759742 MACROMOLECULES ENGINEERED FOR NANOELECTRONIC MEASUREMENT Non-Final OA Universal Sequencing Technology Corporation
18008155 A METHOD FOR DETERMINING KINETIC PARAMETERS OF A REACTION Final Rejection Creoptix AG
17295655 A FLOW CYTOMETRIC DETECTION METHOD FOR LYMPHOCYTE IN IMMUNE CELLS Final Rejection MINGDAO INNOVATION (BEIJING) MEDICAL-TECH CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month